GI Monitor (CA19-9)

The GI Monitor (CA19-9) assay is used for the detection of CA19-9, a biomarker for gastrointestinal cancers, particularly pancreatic cancer. This assay is crucial for early diagnosis, prognosis, and monitoring of treatment efficacy. Designed for Access Series systems, it provides highly accurate results, assisting in the management of gastrointestinal cancer patients.